Leukemia & Lymphoma, Volume 63, Issue 6 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 63, Issue 6 (2022)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Volume 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary

Article Commentary
Is ibrutinib the gold standard for therapy – naive elderly patients with CLL?
Estella Matutes & Aaron Polliack
Pages: 1265-1266
Published online: 25 Mar 2022
CitationforIs ibrutinib the gold standard for therapy – naive elderly patients with CLL? | Full Text | References | PDF (240.1 KB) | EPUB
  • 143 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Current salvage therapies in Hodgkin lymphoma
Karan Chohan & Stephen M. Ansell
Pages: 1267-1280
Published online: 17 Jan 2022
AbstractforCurrent salvage therapies in Hodgkin lymphoma | Full Text | References | PDF (1.1 MB) | EPUB
  • 685 Views
  • 3 CrossRef citations
  • 0Altmetric
Prognostic scoring systems and risk stratification in myelodysplastic syndrome: focus on integration of molecular profile
Somedeb Ball, Rami S. Komrokji & David A. Sallman
Pages: 1281-1291
Published online: 21 Dec 2021
AbstractforPrognostic scoring systems and risk stratification in myelodysplastic syndrome: focus on integration of molecular profile | Full Text | References | PDF (1.1 MB) | EPUB
  • 399 Views
  • 0 CrossRef citations
  • 0Altmetric
The treatment landscape for Relapsed Refractory B Acute Lymphoblastic Leukaemia (ALL)
Kirsty Marie Sharplin & David I Marks
Pages: 1292-1301
Published online: 07 Jan 2022
AbstractforThe treatment landscape for Relapsed Refractory B Acute Lymphoblastic Leukaemia (ALL) | Full Text | References | PDF (979.2 KB) | EPUB
  • 623 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Articles

Article
Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphoma
Sushanth Gouni, Paolo Strati, Gokce Toruner, Akanksha Aradhya, Ralf Landgraf, Daniel Bilbao, Francisco Vega & Nitin Kumar Agarwal
Pages: 1302-1313
Published online: 31 Dec 2021
AbstractforStatins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphoma | Full Text | References | PDF (1.5 MB) | EPUB
  • 448 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Specific TCR V–J gene segment recombinations leading to the identification pan-V–J CDR3s associated with survival distinctions: diffuse large B-cell lymphoma
Konrad J. Cios, Taha I. Huda, Rachel A. Eakins, Moody M. Mihyu & George Blanck
Pages: 1314-1322
Published online: 12 Jan 2022
AbstractforSpecific TCR V–J gene segment recombinations leading to the identification pan-V–J CDR3s associated with survival distinctions: diffuse large B-cell lymphoma | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 113 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Prognostic impact of the controlling nutritional status score in patients with peripheral T-cell lymphoma
Nobuhiko Nakamura, Nobuhiro Kanemura, Shin Lee, Kei Fujita, Tetsuji Morishita, Eri Takada, Yuhei Shibata, Senji Kasahara, Hideko Goto, Kenji Fukuno, Takeshi Hara, Toshiki Yamada, Michio Sawada, Hisashi Tsurumi & Masahito Shimizu
Pages: 1323-1330
Published online: 29 Dec 2021
AbstractforPrognostic impact of the controlling nutritional status score in patients with peripheral T-cell lymphoma | Full Text | References | PDF (1.1 MB) | EPUB
  • 1569 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Lymphocyte HLA-DR/CD-38 co-expression correlates with Hodgkin lymphoma cell cytotoxicity in vitro independent of PD-1/PD1-L pathway
Meret Henry MD MS, Steven Buck MS, Batool Al-Qanber, Manisha Gadgeel & Süreyya Savaşan MD
Pages: 1331-1338
Published online: 08 Jan 2022
AbstractforLymphocyte HLA-DR/CD-38 co-expression correlates with Hodgkin lymphoma cell cytotoxicity in vitro independent of PD-1/PD1-L pathway | Full Text | References | PDF (1.6 MB) | EPUB
  • 162 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse large B-Cell lymphoma
Dong Won Kim, Ali Bukhari, Forat Lutfi, Facundo Zafforoni, Fikru Merechi, Moaath K. Mustafa Ali, David Gottlieb, Seung T. Lee, Mehmet H. Kocoglu, Nancy M. Hardy, Jean Yared, Aaron P. Rapoport, Saurabh Dahiya & Jennie Y. Law
Pages: 1339-1347
Published online: 19 Jan 2022
AbstractforLow utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse large B-Cell lymphoma | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 502 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
High-dose methotrexate dosing strategy in primary central nervous system lymphoma
Alexander Wang, Frank Cirrone, Francis Andrew De Los Reyes, John Papadopoulos, Shella Saint Fleur-Lominy & Elaine Xiang
Pages: 1348-1355
Published online: 04 Feb 2022
AbstractforHigh-dose methotrexate dosing strategy in primary central nervous system lymphoma | Full Text | References | PDF (918.5 KB) | EPUB
  • 388 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
High grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: unraveling the genetic landscape of a rare aggressive subtype of non-Hodgkin lymphoma
Anna Ferrari, Silvia Arniani, Barbara Crescenzi, Stefano Ascani, Leonardo Flenghi, Valentina Pierini, Martina Moretti, Donatella Beacci, Silvia Romoli, Valentina Bardelli, Daniele Calistri, Giovanni Martinelli, Cristina Mecucci & Roberta La Starza
Pages: 1356-1362
Published online: 19 Jan 2022
AbstractforHigh grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: unraveling the genetic landscape of a rare aggressive subtype of non-Hodgkin lymphoma | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 3272 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience
Megan Melody, Sangeetha Gandhi, Hollie Saunders, Zaid Abdel-Rahman, Jacquelyn Hastings, Paula Lengerke Diaz, Nicole Gannon, Tuan Truong, Matthew Hathcock, Arushi Khurana, Patrick Johnston, Stephen Ansell, Nora Bennani, Jonas Paludo, Jose Villasboas Bisneto, Yucai Wang, Allison Rosenthal, James Foran, Ernesto Ayala, Hemant S. Murthy, Vivek Roy, Januario E. Castro, Yi Lin & Mohamed A. Kharfan-Dabaja
Pages: 1363-1368
Published online: 03 Feb 2022
AbstractforIncidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience | Full Text | References | PDF (918.1 KB) | EPUB
  • 450 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Improving outcomes in limited-stage de novo CD5+ DLBCL: systemic approaches with consolidative radiation
Jurui Ge, Yaqin Xia, Zhenchang Sun, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Xudong Zhang, Zhaoming Li, Feifei Nan, Wenjuan Wan, Duo Xu, Jiayin Ding, XiaoRui Fu & Mingzhi Zhang
Pages: 1369-1374
Published online: 06 Jan 2022
AbstractforImproving outcomes in limited-stage de novo CD5+ DLBCL: systemic approaches with consolidative radiation | Full Text | References | PDF (730.7 KB) | EPUB
  • 180 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Up to 6.5 years (median 4 years) of follow-up of first-line ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma and high-risk genomic features: integrated analysis of two phase 3 studies
Jan A. Burger, Tadeusz Robak, Fatih Demirkan, Osnat Bairey, Carol Moreno, David Simpson, Talha Munir, Don A. Stevens, Sandra Dai, Leo W. K. Cheung, Kevin Kwei, Indu Lal, Emily Hsu, Thomas J. Kipps & Alessandra Tedeschi
Pages: 1375-1386
Published online: 11 Jan 2022
AbstractforUp to 6.5 years (median 4 years) of follow-up of first-line ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma and high-risk genomic features: integrated analysis of two phase 3 studies | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 2696 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia
Christopher M. Melén, Magali Merrien, Agata M. Wasik, Georgios Panagiotidis, Olof Beck, Kristina Sonnevi, Henna-Riikka Junlén, Birger Christensson, Birgitta Sander & Björn Engelbrekt Wahlin
Pages: 1387-1397
Published online: 17 Jan 2022
AbstractforClinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 4785 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study
Noémie Gadaud, Harmony Leroy, Emilie Bérard, Suzanne Tavitian, Thibaut Leguay, Sophie Dimicoli-Salazar, Jean-Baptiste Rieu, Isabelle Luquet, Laetitia Largeaud, Audrey Bidet, Eric Delabesse, Emilie Klein, Audrey Sarry, Anne-Charlotte de Grande, Pierre Bories, Arnaud Pigneux, Christian Récher, Pierre-Yves Dumas & Sarah Bertoli
Pages: 1398-1406
Published online: 04 Jan 2022
AbstractforAzacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study | Full Text | References | PDF (1 MB) | EPUB
  • 223 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Pomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-related quality of life results from the phase 2 MM-014 trial
Nizar J. Bahlis, David S. Siegel, Gary J. Schiller, Christy Samaras, Michael Sebag, Jesus Berdeja, Siddhartha Ganguly, Jeffrey Matous, Kevin Song, Christopher S. Seet, Mirelis Acosta-Rivera, Michael Bar, Donald Quick, Bertrand Anz, Gustavo Fonseca, Weiyuan Chung, Kim Lee, Jorge Mouro, Amit Agarwal & Donna Reece
Pages: 1407-1417
Published online: 08 Feb 2022
AbstractforPomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-related quality of life results from the phase 2 MM-014 trial | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 10111 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
A combination of humanized anti-BCMA and murine anti-CD38 CAR-T cell therapy in patients with relapsed or refractory multiple myeloma
Huan Zhang, Man Liu, Xia Xiao, Hairong Lv, Yanyu Jiang, Xin Li, Ting Yuan & Mingfeng Zhao
Pages: 1418-1427
Published online: 01 Feb 2022
AbstractforA combination of humanized anti-BCMA and murine anti-CD38 CAR-T cell therapy in patients with relapsed or refractory multiple myeloma | Full Text | References | PDF (1.6 MB) | EPUB
  • 3043 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Ixazomib in addition to chemotherapy for the treatment of acute lymphoblastic leukemia in older adults
Philip Amrein, Karen Ballen, Kristen Stevenson, Andrew Brunner, Gabriela Hobbs, Hanno Hock, Steven McAfee, Jenna Moran, Meghan Bergeron, Julia Foster, Christina Bertoli, Kristin McGreggor, Molly Macrea, Meghan Burke, Tanya Behnam, Tina Som, Aura Ramos, Megan Vartanian, Jennifer Lombardi Story, Christine Connolly, Traci Blonquist, Donna Neuberg & Amir Fathi
Pages: 1428-1435
Published online: 25 Jan 2022
AbstractforIxazomib in addition to chemotherapy for the treatment of acute lymphoblastic leukemia in older adults | Full Text | References | PDF (766.1 KB) | EPUB
  • 206 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia
Benjamin Kaumeyer, Shiraz Fidai, Madina Sukhanova, Kai Lee Yap, Jeremy Segal, Gordana Raca, Wendy Stock, Jennifer McNeer, Angela M. Lager & Sandeep Gurbuxani
Pages: 1436-1444
Published online: 16 Feb 2022
AbstractforMUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia | Full Text | References | PDF (2.3 MB) | EPUB
  • 241 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
The effects of N-acetylcysteine on experimentally created l-asparaginase-induced liver and pancreatic damage in rats
Gözde Nur Yurttaş, Zeynep Canan Özdemir, Cihan Tanrıkut, Ezgi Kar, Zeynep Küskü Kiraz, Özkan Alataş, Dilek Burukoğlu Dönmez & Özcan Bör
Pages: 1445-1454
Published online: 05 Feb 2022
AbstractforThe effects of N-acetylcysteine on experimentally created l-asparaginase-induced liver and pancreatic damage in rats | Full Text | References | PDF (2.8 MB) | EPUB
  • 188 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Evaluation of central line salvage for mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) management practices in patients with hematologic malignancies
Zeinab El Boghdadly, Qiuhong Zhao, Jean Koutou, Mark E. Lustberg, Madeline Ludwig, Christina Liscynesky & Hannah Choe
Pages: 1455-1463
Published online: 08 Jan 2022
AbstractforEvaluation of central line salvage for mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) management practices in patients with hematologic malignancies | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 1553 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Letters to the Editor

Letter
Progressive multifocal leukoencephalopathy post ibrutinib therapy in relapsed chronic lymphocytic leukaemia
F. Tahir, J. Sy, S. Reddel & J. Trotman
Pages: 1464-1468
Published online: 17 Jan 2022
AbstractforProgressive multifocal leukoencephalopathy post ibrutinib therapy in relapsed chronic lymphocytic leukaemia | Full Text | References | PDF (1.2 MB) | EPUB
  • 185 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
T-cell subset composition and functionality in patients with Waldenström’s macroglobulinemia
Karima Amaador, Anne Martens, Renate de Boer, Joanne Rietveld, Mirjam Heemskerk, Caroline E. Rutten, Eric Eldering, Marie-José Kersten, Arnon P. Kater, Josephine Vos & Sanne Tonino
Pages: 1469-1473
Published online: 01 Feb 2022
First Page PreviewforT-cell subset composition and functionality in patients with Waldenström’s macroglobulinemia | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 175 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment
Silvia Bellesi, Michela Sali, Elena Maiolo, Maria del Carmen Pereyra Boza, Eleonora Alma, Ivana Palucci, Federica Fatone, Flavio De Maio, Marcello Viscovo, Francesco D’Alò, Valerio De Stefano, Stefan Hohaus & Maurizio Sanguinetti
Pages: 1474-1478
Published online: 01 Feb 2022
First Page PreviewforAnti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment | Full Text | References | PDF (1.2 MB) | EPUB
  • 167 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus
Trine Engelbrecht Hybel, Maja Ølholm Vase, Kristina Lystlund Lauridsen, Marie Beck Enemark, Michael Boe Møller, Court Pedersen, Gitte Pedersen, Stephen Hamilton-Dutoit, Niels Obel, Carsten Schade Larsen, Francesco d’Amore & Maja Ludvigsen
Pages: 1479-1483
Published online: 12 Jan 2022
First Page PreviewforCD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 156 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Prognostic impact of CD38 expression in relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma transformation
Fumiya Wada, Yoshimitsu Shimomura, Kimimori Kamijo, Daisuke Yamashita, Aya Ohno, Mayuko Himeno, Hayato Maruoka, Shigeo Hara & Takayuki Ishikawa
Pages: 1484-1487
Published online: 19 Jan 2022
First Page PreviewforPrognostic impact of CD38 expression in relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma transformation | Full Text | References | PDF (601.4 KB) | EPUB | Supplemental
  • 152 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Telehealth access among hematology patients during the COVID-19 pandemic in Australia: a cross-sectional survey
Nienke Zomerdijk, Michelle I Jongenelis, Jane Turner, Kathryn Huntley, Andrew Smith & Camille E. Short
Pages: 1488-1491
Published online: 06 Jan 2022
AbstractforTelehealth access among hematology patients during the COVID-19 pandemic in Australia: a cross-sectional survey | Full Text | References | PDF (544.4 KB) | EPUB
  • 264 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Prognostic value of early imaging following CAR-T cell therapy in diffuse large B-cell lymphoma
Amneet Bajwa, Ying Huang, Rui Li, Nathan Denlinger, Jonathan Brammer, Sam Penza, Ayman Saad, Samantha Jaglowski & Adam S. Kittai
Pages: 1492-1495
Published online: 03 Feb 2022
First Page PreviewforPrognostic value of early imaging following CAR-T cell therapy in diffuse large B-cell lymphoma | Full Text | References | PDF (706.9 KB) | EPUB
  • 257 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Clinicoradiopathological correlation of symptomatic focal bone marrow lesions in Waldenström Macroglobulinaemia
Suzanne O. Arulogun, Maaz Ali Abbasi, Sabine Pomplun, Aideen T. O’Neill, Simon Wan, Ashutosh Wechalekar & Shirley P. D’Sa
Pages: 1496-1499
Published online: 22 Jan 2022
First Page PreviewforClinicoradiopathological correlation of symptomatic focal bone marrow lesions in Waldenström Macroglobulinaemia | Full Text | References | PDF (803.4 KB) | EPUB
  • 72 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Rapid liver atrophy and refractory ascites due to hepatoportal sclerosis in a patient after haploidentical stem cell transplantation
Daisuke Ikeda, Takafumi Tsushima, Ami Fukumoto, Ayumi Kuzume, Rikako Tabata, Toshiki Terao, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Koichi Honma & Kosei Matsue
Pages: 1500-1503
Published online: 12 Jan 2022
First Page PreviewforRapid liver atrophy and refractory ascites due to hepatoportal sclerosis in a patient after haploidentical stem cell transplantation | Full Text | References | PDF (1.3 MB) | EPUB
  • 72 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Long-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: results from a seroprevalence study
Simone Claudiani, Eleanor L. Parker, Dragana Milojkovic, Carolina Rosadas, Afzal Khan, Ksenia Katsanovskaja, Federica Marchesin, Maryam Khan, Richard S. Tedder, Andrew J. Innes, Myra O. McClure & Jane F. Apperley
Pages: 1504-1507
Published online: 24 Jan 2022
First Page PreviewforLong-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: results from a seroprevalence study | Full Text | References | PDF (534.3 KB) | EPUB | Supplemental
  • 171 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Effectiveness and safety of R-GCD (rituximab, gemcitabine, carboplatin, and dexamethasone) for transplant-ineligible relapse/refractory diffuse large B-cell lymphoma and grade 3a follicular lymphoma: a retrospective analysis comparing with R-GDP (rituximab, gemcitabine, cisplatin, and dexamethasone)
Ryosuke Naka, Kohei Tada, Hitomi Kaneko, Osamu Nagata, Masaharu Tashima, Chisato Mizutani & Kazunori Imada
Pages: 1508-1511
Published online: 02 Feb 2022
First Page PreviewforEffectiveness and safety of R-GCD (rituximab, gemcitabine, carboplatin, and dexamethasone) for transplant-ineligible relapse/refractory diffuse large B-cell lymphoma and grade 3a follicular lymphoma: a retrospective analysis comparing with R-GDP (rituximab, gemcitabine, cisplatin, and dexamethasone) | Full Text | References | PDF (514.4 KB) | EPUB | Supplemental
  • 439 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia
Francesca Fazio, Gabriella Cunsolo, Francesca Mancini, Maria Stefania De Propris, Alfonso Piciocchi, Valentina Arena, Monica Messina, Michela Ansuinelli, Akram Taherinasab Taherinasab, Valerio Apicella, Antonella Vitale, Sabina Chiaretti, Anna Guarini, Ilaria del Giudice & Robin Foà
Pages: 1512-1514
Published online: 08 Feb 2022
First Page PreviewforBlast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia | Full Text | References | PDF (514.4 KB) | EPUB
  • 139 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF)
Aleksander L. Chojecki, Kristyn Y. DiSogra, Justin Arnall, Nicole Cowgill, Amy Soni, Charles H. Packman, Srinivasa Reddy Sanikommu, Nilay A. Shah, Brittany K. Ragon, Thomas G. Knight, Jing Ai, Belinda R. Avalos, Edward A. Copelan & Michael R. Grunwald
Pages: 1515-1517
Published online: 02 Feb 2022
First Page PreviewforOptimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF) | Full Text | References | PDF (412.2 KB) | EPUB
  • 177 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles